Valvular Heart Disease in Heart Failure

Giuseppe Rosano


Structural valvular heart disease may be the cause of heart failure or may worsen the clinical status of patients with heart failure. Heart failure may also develop in patients treated with valve surgery. Patients with heart failure with valvular heart disease are at increased risk of events including sudden cardiac death. Before considering intervention (surgical or percutaneous) all patients should receive appropriate medical and device therapy taking into account that vasodilators must be used with caution in patients with severe aortic stenosis. Numerous percutaneous and/or hybrid procedures have been introduced in the past few years and they are changing the management of valvular heart disease. In patients with heart failure and valvular heart disease, either primary or functional, the whole process of decision-making should be staged through a comprehensive evaluation of the risk– benefit ratio of different treatment strategies and should be made by a multidisciplinary ‘heart team’ with a particular expertise in valvular heart disease. The heart team should include heart failure cardiologists, cardiac surgeons/structural valve interventionists, imaging specialists, anaesthetists, geriatricians and intensive care specialists. This article will review recent developments and distill practical guidance in the management of this important heart failure co-morbidity.


Heart Valve disease; Heart failure; Congenital heart disease; Cardiovascular imaging; Echocardiography; CMR; PET; Cardiac CT; Guidelines

Full Text:

453 HTML


Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio- Thoracic Surgery (EACTS). Eur Heart J 2012; 33: 2451–2496.

Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2438–2488.

Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009; 373: 956–966.

Clark C. Relation between pressure difference across the aortic valve and left ventricular outflow. Cardiovasc Res. 1978; 12: 276–287.

Dumesnil JG, Pibarot P, Carabello B. Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment. Eur Heart J. 2010; 31: 281–289.

Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic- valve replacement in high- risk patients. N Engl J Med 2011; 364: 2187–2198

Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597–1607.

Reardon MJ, Adams DH, Kleiman NS, et al. 2- Year outcomes in patients undergoing surgical or self- expanding transcatheter aortic valve replacement. J Am Coll Cardiol 2015; 66: 113–121.

Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic- valve replacement with a self- expanding prosthesis. N Engl J Med 2014; 370: 1790–1798.

Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013; 14: 611–644.

Chaliki HP, Mohty D, Avierinos JF, et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 2002; 106: 2687–2693.

Smith PK, Puskas JD, Ascheim DD, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2014; 371: 2178–2188.

Acker MA, Parides MK, Perrault LP, et al. Mitral- valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2014; 370: 23–32.

Lebrun F, Patrizi P, Pierard L. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. Journal of the American College of Cardiology 2001: 38: 1685–1692.

Schmitto JD, Lee LS, et al. Functional mitral regurgitation Cardiology Review 2010 Nov – Dec; 18(6): 285–91.

Michelena H, Valentina B, et al. Progress in the Treatment of Severe Mitral Regurgitation – Rev Esp Cardiology 2010; 63: 820–31 – Vol. 63 Num 07.

Otsuji Y, Handschumacher MD, Schwammenthal E, et al. Insights from three- dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation 1997; 96: 1999–2008.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, et al.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592.

D’ascenzo F, Moretti C, Marra WG, et al. Meta- analysis of the usefulness of mitraclip in patients with functional mitral regurgitation. Am J Cardiol 2015; 116: 325–331.

Nickenig G, Estevez- Loureiro R, Franzen O, et al. Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology. Percutaneous mitral valve edge- to- edge repair: in- hospital results and 1- year follow- up of 628 patients of the 2011–2012 pilot European Sentinel Registry. J Am Coll Cardiol 2014; 64: 875–884.

Perez- Ayuso RM, Arroyo V, Planas R, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin- aldosterone system. Gastroenterology 1983; 84: 961–968.

Schofer J, Bijuklic K, Tiburtius C, Hansen L, Groothuis A, Hahn RT. First- in- human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol 2015; 65: 1190–1195.

Shewan L.G., Coats A.J.S., Henein M. Requirements for Ethical Publishing in Biomedical Journals. International Cardiovascular Forum Journal. 2015;2:2.


Copyright (c) 2017 The Author

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.